Increase in protein expression of the transcription factors SNAIL (SNAI2) and SLUG (SNAI1) in progranulin-treated MDA-MB 231 breast cancer cells. MDA-MB 231 cells treated with either vehicle (PBS) or 1 μg/ml progranulin (×) and analysed for protein expression (Western blot). Left box illustrates protein ladder and targeted proteins at different exposure times. (TIFF 1453 kb
Figure S2. SOX2 knockdown reduces growth of fulvestrant-resistant breast cancer cells. (A) 182R-1 fu...
Figure S1. Protein activity suppressed by inhibitors. Western blot quantification and short time poi...
Figure S3. Correlation between SNAI2 expression and PFS in patients with ER+ metastatic breast cance...
Decreased proliferation of nuclear stained GFP-Sox2 reporter cells at 72 h of treatment. Percentage ...
The small orally available sortilin inhibitor AF38469 do not impact cell viability. Relative prolife...
Figure S1. SNAI2 and E-cadherin protein levels following siRNA-mediated SNAI2 knockdown. MCF-7-based...
Figure S1. miR-140-3p-1 modestly inhibits proliferation of breast preneoplastic cells. (A) Immunoflu...
Figure S1. Effects of VPA and SAHA treatments on Ca2+ pump expressions in different breast cancer ce...
Clonal GFP+ TC2GR12 (TC2) and TC4GR5 (TC4) cells are ERα+, PRLR+, and express the signal mediators, ...
Figure S1: (A) Dysregulation score was calculated according to Pathifier [32] for MAPK and JAK/STAT ...
Figure S1. Protein level of OCT4 as detected by western blotting after the NC siRNA group or the US...
Figure S1. MASTL is associated with poor prognosis in breast cancer. The survival of MASTL in breast...
Figure S1. PTEN protein abundance of breast cancer cell lines. (A) Western blots showing PTEN and ac...
Figure S1. Gene expression in breast cancer. a Volcano plot of gene expression changes in the transc...
Expression of different markers in various breast cancer cell lines. Western blot showing different ...
Figure S2. SOX2 knockdown reduces growth of fulvestrant-resistant breast cancer cells. (A) 182R-1 fu...
Figure S1. Protein activity suppressed by inhibitors. Western blot quantification and short time poi...
Figure S3. Correlation between SNAI2 expression and PFS in patients with ER+ metastatic breast cance...
Decreased proliferation of nuclear stained GFP-Sox2 reporter cells at 72 h of treatment. Percentage ...
The small orally available sortilin inhibitor AF38469 do not impact cell viability. Relative prolife...
Figure S1. SNAI2 and E-cadherin protein levels following siRNA-mediated SNAI2 knockdown. MCF-7-based...
Figure S1. miR-140-3p-1 modestly inhibits proliferation of breast preneoplastic cells. (A) Immunoflu...
Figure S1. Effects of VPA and SAHA treatments on Ca2+ pump expressions in different breast cancer ce...
Clonal GFP+ TC2GR12 (TC2) and TC4GR5 (TC4) cells are ERα+, PRLR+, and express the signal mediators, ...
Figure S1: (A) Dysregulation score was calculated according to Pathifier [32] for MAPK and JAK/STAT ...
Figure S1. Protein level of OCT4 as detected by western blotting after the NC siRNA group or the US...
Figure S1. MASTL is associated with poor prognosis in breast cancer. The survival of MASTL in breast...
Figure S1. PTEN protein abundance of breast cancer cell lines. (A) Western blots showing PTEN and ac...
Figure S1. Gene expression in breast cancer. a Volcano plot of gene expression changes in the transc...
Expression of different markers in various breast cancer cell lines. Western blot showing different ...
Figure S2. SOX2 knockdown reduces growth of fulvestrant-resistant breast cancer cells. (A) 182R-1 fu...
Figure S1. Protein activity suppressed by inhibitors. Western blot quantification and short time poi...
Figure S3. Correlation between SNAI2 expression and PFS in patients with ER+ metastatic breast cance...